Employees
~100
Stage
Commercial
Modalities
Medical devices

Sequel Med Tech General Information

FDA-cleared automated insulin delivery (AID) system with direct measurement of insulin volume delivery and integration with Abbott's FreeStyle Libre 3 Plus CGM sensor. System features iiSure Technology with four checkpoints for accurate delivery and faster blockage detection.

Contact Information

Website
Primary Industry
Medical Devices
Corporate Office
Manchester, New Hampshire
United States

Drug Pipeline

twiist
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Sequel Med Tech's pipeline data

Book a demo

Key Partnerships

Abbott, Tidepool

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Sequel Med Tech Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Sequel Med Tech's complete valuation and funding history, request access »